Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Cash from Restructuring (2009 - 2018)

Fresenius Medical Care AG (FMS) posted Cash from Restructuring of $51.4 million for Q4 2018, down 13.93% on a QoQ basis from $59.7 million in Q2 2018, and down 14.47% year-over-year from $60.0 million in Q4 2017.

Fresenius Medical Care AG (FMS) has 6 years of Cash from Restructuring data on file, last reported at $51.4 million in Q4 2018.

  • In Q4 2018, Cash from Restructuring fell 14.47% year-over-year to $51.4 million; the TTM figure through Dec 2018 stood at $51.4 million (down 14.47% YoY), while the FY2018 annual figure was $51.4 million, down 14.47% from the prior year.
  • Cash from Restructuring fell to $51.4 million in Q4 2018, from $59.7 million in the prior quarter.
  • Across five years, Cash from Restructuring topped out at $70.2 million in Q4 2016 and bottomed at $51.4 million in Q4 2018.
  • A 3-year average of $60.9 million and a median of $60.0 million in 2017 frame the typical range for Cash from Restructuring.
  • Annual changes were most pronounced in 2017 — Cash from Restructuring slipped 14.44% — and 2018, when it dropped 14.47%.
  • Year by year, Cash from Restructuring stood at $70.2 million in 2016, then dropped by 14.44% to $60.0 million in 2017, then decreased by 14.47% to $51.4 million in 2018.
  • The last three Cash from Restructuring figures came in at $51.4 million (Q4 2018), $59.7 million (Q2 2018), and $60.0 million (Q4 2017), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 84.64 Bn 87.02 Bn 16.26 Bn
2 Tenet Healthcare 15.22 Bn 14.39 Bn 4.41 Bn
3 Davita 13.10 Bn 13.96 Bn 1.07 Bn
4 Encompass Health 10.50 Bn 11.12 Bn 1.34 Bn
5 Ensign 9.69 Bn 9.09 Bn 293.37 Mn
6 Universal Health Services 8.92 Bn 8.88 Bn 3.21 Bn
7 Fresenius Medical Care AG 7.31 Bn 4.93 Bn 22,843.10 Bn
8 Chemed 5.83 Bn 5.81 Bn 215.76 Mn
9 Pacs 5.76 Bn 5.51 Bn 345.96 Mn
10 Option Care Health 3.27 Bn 3.09 Bn 262.01 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2018 51.36 Mn
Jun 30, 2018 59.67 Mn
Dec 31, 2017 60.05 Mn
Sep 30, 2017 63.45 Mn
Dec 31, 2016 70.18 Mn
Dec 31, 2011 1.00 Mn
Dec 31, 2010 -3.00 Mn
Mar 31, 2010 51.00 Mn
Mar 31, 2009 45.00 Mn